Predictive marker discovery for Sorafenib using patient derived xenograft models of hepatocellular carcinoma

被引：0
|
作者：
Zhang, Juan [1 ]
Sun, Yanmei [1 ]
Song, Xiaoming [1 ]
Yang, Jie [1 ]
Cai, Jie [1 ]
Shi, Qian [1 ]
Chen, Taiping [1 ]
机构：
[1] Crown Biosci Inc, Div Translat Oncol, Santa Clara, CA USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-1877
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1877
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sorafenib/Refametinib potently inhibits Wnt/β-catenin in vitro and patient-derived xenograft models of human hepatocellular carcinoma
    Hung, Huynh T.
    Ong, Richard
    Puehler, Florian
    Scholz, Arne
    Politz, Oliver
    Zopf, Dieter
    Mumberg, Dominik
    Ziegelbauer, Karl
    CANCER RESEARCH, 2016, 76
  • [2] Comprehensive comparison of patient-derived xenograft models in Hepatocellular Carcinoma and metastatic Liver Cancer
    Xu, Wei
    Zhao, Zheng-Yun
    An, Qi-Ming
    Dong, Bin
    Lv, Ang
    Li, Cheng-peng
    Guan, Xiao-Ya
    Tian, Xiu-Yun
    Wu, Jian-Hui
    Hao, Chun-Yi
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (18): : 3073 - 3081
  • [3] High spatiotemporal heterogeneity, clonal selection and neoantigen evolution in acquired sorafenib-resistant patient-derived xenograft models of hepatocellular carcinoma.
    Yang, Xin-Rong
    Hu, Bo
    Zhou, Wan
    Fan, Jia
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Comparing the Efficacy of Sunitinib with Sorafenib in Xenograft Models of Human Hepatocellular Carcinoma: Mechanistic Explanation
    Huynh, H.
    Choo, S. P.
    Toh, H. C.
    Tai, W. M.
    Chung, A. Y. F.
    Chow, P. K. H.
    Ong, R.
    Soo, K. C.
    CURRENT CANCER DRUG TARGETS, 2011, 11 (08) : 944 - 953
  • [5] DES-GAMMA-CARBOXY PROTHROMBIN IS A PREDICTIVE MARKER IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA WITH SORAFENIB
    Ueshima, Kazuomi
    Kudo, Masatoshi
    HEPATOLOGY, 2010, 52 (04) : 1182A - 1183A
  • [6] Patient-derived tumor xenograft models for melanoma drug discovery
    Harris, Antoneicka L.
    Joseph, Richard W.
    Copland, John A.
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (09) : 895 - 906
  • [7] Sorafenib in hepatocellular carcinoma:efficacy and predictive factors
    Li Jing
    Journal of Medical Colleges of PLA, 2011, (06) : 324 - 334
  • [8] Patient-derived xenograft models of breast cancer and their predictive power
    James R Whittle
    Michael T Lewis
    Geoffrey J Lindeman
    Jane E Visvader
    Breast Cancer Research, 17
  • [9] Patient-derived xenograft models of breast cancer and their predictive power
    Whittle, James R.
    Lewis, Michael T.
    Lindeman, Geoffrey J.
    Visvader, Jane E.
    BREAST CANCER RESEARCH, 2015, 17
  • [10] Varlitinib to demonstrate anti-tumour efficacy in patient-derived hepatocellular carcinoma xenograft models.
    Hsieh, Chih-Yi
    Ooi, Lisa
    Ong, Richard Weijie
    Lindmark, Bertil
    McHale, Mark
    Hung The Huynh
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345